AVNS Avanos Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AVNS

Price (delayed)

$31.5

Market cap

$1.52B

P/E Ratio

787.5

Dividend/share

N/A

EPS

$0.04

Enterprise value

$1.64B

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights
The net income has soared by 114% YoY and by 106% from the previous quarter
The EPS has soared by 112% YoY and by 105% from the previous quarter
The quick ratio has declined by 28% year-on-year
The gross margin has declined by 12% year-on-year and by 3.4% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://avanos.com/
Peers: SIEN

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
48.12M
Market cap
$1.52B
Enterprise value
$1.64B
Valuations
Price to earnings (P/E)
787.5
Price to book (P/B)
1.17
Price to sales (P/S)
2.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.23
Earnings
Revenue
$737.8M
EBIT
-$64.3M
EBITDA
-$23.6M
Free cash flow
-$5.4M
Per share
EPS
$0.04
Free cash flow per share
-$0.11
Book value per share
$26.97
Revenue per share
$15.35
TBVPS
$15.21
Balance sheet
Total assets
$1.68B
Total liabilities
$387M
Debt
$227.4M
Equity
$1.3B
Working capital
$285.2M
Liquidity
Debt to equity
0.18
Current ratio
2.8
Quick ratio
1.31
Net debt/EBITDA
-5.4
Margins
EBITDA margin
-3.2%
Gross margin
49%
Net margin
0.3%
Operating margin
1.7%
Efficiency
Return on assets
0.1%
Return on equity
0.2%
Return on invested capital
-9%
Return on capital employed
-4.2%
Return on sales
-8.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
-0.1%
1 week
-4.26%
1 month
-4.4%
1 year
-8.22%
YTD
-31.34%
QTD
-13.39%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$737.8M
Gross profit
$361.7M
Operating income
$12.9M
Net income
$2.4M
Gross margin
49%
Net margin
0.3%
The net income has soared by 114% YoY and by 106% from the previous quarter
Avanos Medical's net margin has soared by 113% YoY and by 106% from the previous quarter
The gross margin has declined by 12% year-on-year and by 3.4% since the previous quarter
Avanos Medical's operating margin has decreased by 11% from the previous quarter

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
P/E
787.5
P/B
1.17
P/S
2.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.23
The EPS has soared by 112% YoY and by 105% from the previous quarter
AVNS's price to book (P/B) is 27% less than its 5-year quarterly average of 1.6 and 22% less than its last 4 quarters average of 1.5
The company's equity rose by 3.5% QoQ and by 2.8% YoY
The P/S is 51% lower than the 5-year quarterly average of 4.2 and 21% lower than the last 4 quarters average of 2.6
The revenue is up by 4.6% year-on-year and by 3.2% since the previous quarter

Efficiency

How efficient is Avanos Medical business performance
The ROE has soared by 115% YoY and by 107% from the previous quarter
The return on assets has surged by 111% year-on-year and by 105% since the previous quarter
AVNS's ROIC is down by 11% from the previous quarter
The ROS has contracted by 6% from the previous quarter

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
The quick ratio has declined by 28% year-on-year
Avanos Medical's total liabilities has decreased by 22% YoY and by 2.3% from the previous quarter
Avanos Medical's debt is 82% less than its equity
The debt to equity has contracted by 31% YoY and by 5% from the previous quarter
Avanos Medical's debt has decreased by 30% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.